Balancing Inflammation: Computational Design of Small-Molecule Toll-like Receptor Modulators

Trends Pharmacol Sci. 2017 Feb;38(2):155-168. doi: 10.1016/j.tips.2016.10.007. Epub 2016 Nov 15.

Abstract

As essential proteins of the innate immune system, Toll-like receptors (TLRs) are involved in a plethora of physiological pathologies and their modulation is an ongoing quest in the field of drug discovery. Although TLRs recognize an unusually broad range of different molecular patterns, only a few small-molecule TLR modulators have been reported to date. Recent advances in crystallography and in silico techniques provide promising opportunities for TLR investigations and drug design. Here, three application areas for computational approaches are considered: (i) exploration of TLR structure and activation; (ii) understanding TLR modulation; and (iii) TLR drug discovery. By providing an overview on state-of-the-art computational methods, we highlight the value of molecular modeling in mechanistically understanding TLR function and guiding drug design.

Keywords: Toll-like receptor; drug design; inflammation; virtual screening.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Drug Design
  • Drug Discovery*
  • Humans
  • Inflammation / drug therapy*
  • Mice
  • Models, Molecular
  • Molecular Docking Simulation
  • Quantitative Structure-Activity Relationship
  • Toll-Like Receptors / chemistry
  • Toll-Like Receptors / drug effects*
  • Toll-Like Receptors / physiology

Substances

  • Toll-Like Receptors